21. November 2009 00:32
Pfizer today announced that the U.S. Food and Drug Administration (FDA) has approved Geodon® (ziprasidone HCI) Capsules for maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate in adults. The approval is based on clinical data demonstrating that Geodon is an effective and generally well-tolerated adjunctive treatment for long-term symptom control in patients with bipolar disorder.
[More]
e509995b-1b4e-4e92-b105-966405d5524b|1|5.0
Posted in: Medical Condition News | Pharmaceutical News
Tags: Antipsychotic, Arrhythmia, Bipolar Disorder, Blood Pressure, Dementia, Diabetes, Hyperglycemia, Mental Health, Pfizer, Pharmacology, Psychiatry, Psychosis, Schizophrenia
20. November 2009 23:40
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.
[More]
eb34af81-8141-4574-b270-52cb5d01cd03|0|.0
Posted in: Child Health News | Pharmaceutical News
Tags: Abilify, Antidepressant, Antipsychotic, Autism, Bipolar Disorder, Blood Pressure, Cardiovascular Disease, Cell, Cerebrovascular Disease, Constipation, Creatinine, Dehydration, Dementia, Depression, Diabetes, Diabetes Mellitus, Dystonia, Exercise, Heart Failure, Hyperglycemia, Hypersensitivity, Insomnia, Leukopenia, Lipids, Nausea, Neutropenia, New Drug Application, Obesity, Pediatrics, Pneumonia, Psychosis, Schizophrenia, Speech, Stroke, Tardive Dyskinesia, Urticaria, Vomiting
19. November 2009 04:18
To help bring greater certainty to the measurement of medication levels in a patient's bloodstream for three drugs with narrow therapeutic ranges, the U.S. Pharmacopeial Convention (USP) is releasing new certified reference materials (CRMs).
[More]
19. November 2009 04:06
Thanks to a $50,000 grant from the California Bipolar Foundation (CBF) to post-doctoral research fellow Dr. Illyas Singec at the Burnham Institute for Medical Research (BIMR), a research team headed by Dr. Evan Snyder (along with co-investigators Drs. Dieter Wolfe and Lawrence Brill), was able to accumulate sufficient preliminary data to win an extremely competitive Grand Opportunities (GO) grant from the National Institute of Mental Health to explore the molecular basis of Bipolar Disorder (BPD).
[More]
18. November 2009 07:25
On November 9, 2009, Honorable Speaker of the Senate Ron Ramsey, and Honorable Senator Mark Norris issued the first proclamation in support of a Mental Health initiative in the state of Tennessee. This is a major breakthrough to benefit people living with bipolar disorder in the State of Tennessee, and support The Brilliance in Bipolar Initiative.
[More]
18. November 2009 06:57
An estimated 26,000 Nova Scotians live with bipolar disorder. Often stigmatized in popular culture, the experience of bipolar disorder varies from one person to the next and almost always has a drastic impact on how individuals think, behave and function.
[More]
17. November 2009 05:19
Research and Markets has announced the addition of Decision Resources, Inc.'s new report "The Psychiatric Disease Pipeline: A Strategic Review" to their offering.
[More]
17. November 2009 00:43
A protein long thought to be a secondary regulator in the heart's response to stressors like hypertension actually appears to be a primary regulator according to researchers from the Center for Translational Medicine at Thomas Jefferson University.
[More]
17. November 2009 00:09
Many Americans suffer from bipolar disorder and their treatment often includes myriad medications. But what if there is another way to cope with the illness that comes from within? In his revolutionary new guidebook, "Living Out of Darkness: A personal journey of embracing the bipolar opportunity" (published by AuthorHouse), George Denslow -- who was diagnosed bipolar at age 17 -- presents a comprehensive, in-depth look at how to manage bipolar symptoms using a technique he calls "unmedicated spiritual engagement."
[More]
16. November 2009 05:57
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse-. In this study, Vyvanse demonstrated significant improvement in Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms as measured by the ADHD Rating Scale IV (ADHD-RS IV) and Connors' Parent Rating Scale-Revised Short (CPRS-RS) in children with ADHD aged 6 to 12 years.
[More]
61ba286d-5b3b-4047-95a2-27f2235034f8|0|.0
Posted in: Child Health News | Drug Trial News
Tags: Abdominal Pain, Arteriosclerosis, Bipolar Disorder, Blood Pressure, Cardiovascular Disease, CDC, Depression, Drug Abuse, Glaucoma, Headache, Hypersensitivity, Hyperthyroidism, Insomnia, Nausea, Psychiatry, Psychosis, Stroke, Vomiting
13. November 2009 04:41
Shire plc, the global specialty biopharmaceutical company, announced findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse®. In this study, Vyvanse demonstrated significant improvement in Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms as measured by the ADHD Rating Scale IV (ADHD-RS IV) and Connors' Parent Rating Scale-Revised Short (CPRS-RS) in children with ADHD aged 6 to 12 years.
[More]
0d7781a0-d746-4dd4-9500-ffd869a3587b|0|.0
Posted in: Child Health News | Pharmaceutical News
Tags: Abdominal Pain, Arteriosclerosis, Bipolar Disorder, Blood Pressure, Cardiovascular Disease, CDC, Depression, Drug Abuse, Glaucoma, Headache, Hypersensitivity, Hyperthyroidism, Insomnia, Nausea, Psychiatry, Psychosis, Stroke, Vomiting
13. November 2009 04:35
On November 17 at 2:00 pm, Memphis Mayor AC Wharton will announce during a press conference at the University of Tennessee Health Science Center his support for the a new cooperative venture that assists individuals with bipolar disorder.
[More]
12. November 2009 03:39
Memphis Mayor, A.C. Wharton stands up for the outstanding Memphis-based National Bipolar Foundation; a press conference is to be hosted by University of Tennessee Health & Science Center on November 17th at 2pm at the Student Center at 800 Madison in Room 305.
[More]
11. November 2009 23:55
Malfunctioning circadian clock genes may be responsible for bipolar disorder in children. Researchers writing in the open access journal BMC Psychiatry found four versions of the regulatory gene RORB that were associated with pediatric bipolar disorder.
[More]
11. November 2009 23:26
Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced the re-launch of FOCUS (http://www.vyvanseFOCUS.com), a free, online patient support program for adults taking once-daily Vyvanse® (lisdexamfetamine dimesylate) Capsules CII for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD), and the only online, branded personalized patient support program providing tips and tools for adults diagnosed with ADHD taking a prescription medication.
[More]
687adcd8-f7fd-4a08-b6cf-0520253d29b7|0|.0
Posted in: Medical Condition News | Healthcare News
Tags: Allergy, Arteriosclerosis, Bipolar Disorder, Blood Pressure, CDC, Depression, Glaucoma, Hyperthyroidism, Pseudoephedrine, Psychiatry, Psychosis
Subscribe